Latest News about Vaccinations
Recent news which mentions Vaccinations
Covid-19, flu, RSV: Vaccine recommendations for fall—and the best time to get them
September 06, 2024
From CNBC.com News
CNBC Daily Open: Stocks slide ahead of Powell speech
August 22, 2024
From CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
From CNBC.com News
CNBC Daily Open: Roaring Kitty's wealth, Modi's victory
June 04, 2024
From CNBC.com News
CNBC Daily Open: GameStop can't stop, Dow drops
June 04, 2024
From CNBC.com News
Nobel Prize winner Katalin Karikó was 'demoted 4 times' at her old job. How she persisted: 'You have to focus on what's next'
October 06, 2023
From CNBC.com News
Covid-19, flu, RSV: Here are the vaccine recommendations for fall—and the best time to get them
September 12, 2023
From CNBC.com News
Moderna says updated Covid vaccine was effective against highly mutated BA.2.86 variant in trial
September 06, 2023
From CNBC.com News
New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant
August 18, 2023
From CNBC.com News
From CNBC.com News
New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
July 29, 2023
From CNBC.com News
GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales
July 26, 2023
From CNBC.com News
From CNBC.com News
Biden administration asks Pfizer, Moderna and Novavax for 'reasonable' prices on updated Covid vaccines
July 13, 2023
From CNBC.com News
Novavax stock spikes 20% after company snags $350 million from Canada for unused Covid shots
July 10, 2023
From CNBC.com News
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says
June 22, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
FDA advisors recommend that new Covid vaccines target an omicron XBB variant this fall
June 15, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
February 24, 2023
From CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
January 18, 2023
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.